Patients who went through the SEE program in Michigan were more likely to stick to their drug regimen and reported less ...

Building on prior Ophthalmology Times coverage examining how ophthalmic drug shortages are both more frequent and longer-lasting than the national average, Ian Pitha, MD, PhD, an ophthalmologist at ...

Explore the latest research on glaucoma treatment and the role of immune cells in eye pressure regulation for better outcomes.

Glaucoma medication adherence and glaucoma-related distress were both improved when patients used the Support, Educate, Empower (SEE) glaucoma coaching program vs the standard written education ...

AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk ...

Topical brimonidine is linked to a significantly increased risk for trabeculectomy failure in patients with glaucoma due to elevated intraocular pressure.

A Support, Educate, Empower (SEE) glaucoma coaching program improves medication adherence compared with standard written education, according to a study published online Feb. 26 in JAMA Ophthalmology.

Explore the silent thief of sight: glaucoma. This article sheds light on the urgent need for awareness and action to prevent ...

Experts explain whether Lasik or lens implants affect your risk, and how a hair strand-like microshunt could reduce reliance on lifelong eye drops for patients.

A 1:1 randomized clinical trial compared personalized coaching plus electronic adherence monitoring against standard mailed education, with both groups continuing usual glaucoma care. Participants ...

Glaucoma causes irreversible vision loss affecting 80 million people; World Glaucoma Week 2026 urges early eye exams, awareness, and treatment to prevent blindness.